OFF-BRAND STI571: A BUDGET-FRIENDLY OPTION?

The arrival of common imatinib represents a significant opportunity for patients battling a certain type of cancer and other diseases. Original brand-name imatinib, branded as Gleevec, carries a considerable price cost, frequently making it accessibility for some individuals. Common versions, usu